Halper Sadeh LLC is investigating whether shareholders of Arcosa, Bio-Techne, Iridium Communications, and LCI Industries are receiving fair deals in their companies' recent sales. The law firm suspects insiders may gain financial benefits not available to ordinary shareholders and that deal terms might limit better competing offers. Shareholders are encouraged to contact the firm for free legal advice and potential claims to seek increased compensation or disclosures. This investigation highlights concerns over shareholder rights in major corporate transactions.
Brodsky & Smith LLC has announced investigations into whether the boards of LCI Industries, Iridium Communications, Bio-Techne Corporation, and Arcosa breached their fiduciary duties during recent merger agreements. The investigations focus on whethe...
The global molecular biology enzymes, reagents, and kits market is projected to grow from $27.69 billion in 2025 to $70.85 billion by 2035, at a CAGR of 9.68%. Growth is fueled by rising use of molecular diagnostics, genomics research, and precision ...
Ademi LLP is investigating Bio-Techne's $11.3 billion acquisition by Merck, questioning if public shareholders are receiving a fair price of $73 per share. The law firm alleges possible breaches of fiduciary duty by Bio-Techne's board and highlights ...
